Previous Chapter Chapter 14: The Impact of German Reference Pricing on Statins Next Chapter

By: Decision Resources Inc

In: The SAGE Handbook of Healthcare

Chapter 14: The Impact of German Reference Pricing on Statins

  • Citations
  • Add to My List
  • Text Size

The Impact of German Reference Pricing on Statins
The impact of German reference pricing on statins
Introduction

Dyslipidemia is a largely asymptomatic disorder that seriously increases the cardiovascular risk of the majority of the adult population in Germany and other industrialized nations. Inadequate treatment of dyslipidemia can lead to coronary heart disease (CHD) or stroke, events that can have devastating or even fatal consequences.

The size of the dyslipidemic population and the severity of this disease and its complications make dyslipidemia a major public health issue for all industrialized nations. The German government is acutely conscious of the need to tackle this problem, but it has also been struggling for many years to slow down the relentless growth of public healthcare expenditures. The government has focused its cost-containment ...

Looks like you do not have access to this content.

Login

Don’t know how to login?

Click here for free trial login.

Back to Top

Copy and paste the following HTML into your website